Hepatic insulin sensitivity assessed by integrated model of hepatic and peripheral glucose regulation.

BACKGROUND The integrated model of hepatic and peripheral glucose metabolism incorporates a model for liver glucose metabolism into the two-compartment minimal model framework to describe endogenous glucose kinetics during a labeled intravenous glucose tolerance test (IVGTT). This model also provides a parametric description of endogenous glucose production (EGP). The present study extended the theoretical potential of the model by defining hepatic glucose effectiveness (hS(G)(2)) as the ability of glucose per se to inhibit EGP and hepatic insulin sensitivity (hS(1)(2)) as the ability of insulin to enhance glucose suppression of EGP. METHODS As a retrospective data base review of our previous study, we re-analyzed time courses of exogenous and endogenous glucose concentration during [6,6-(2)H(2)]glucose-labeled IVGTT (0.3 g/kg glucose), performed in 11 exercise-trained and 12 age-matched sedentary subjects. Model parameters of the two-compartment minimal model and of liver glucose metabolism were simultaneously identified to assess insulin sensitivity specific to stimulate glucose uptake (S(1)(2*)) and that specific to inhibit EGP (hS(1)(2)). The abilities of glucose per se to stimulate its own uptake (S(G)(2*)) and to inhibit EGP (hS(G)(2)) were also estimated. RESULTS Parameters of the integrated model were identified in all the subjects. Hepatic insulin sensitivity consisted of about one-third of total insulin sensitivity (S(1)(2*) + hS(1)(2)). Compared with the sedentary subjects, S(1)(2*), hS(1)(2), hS(G)(2) of the trained subjects were greater. CONCLUSIONS Because insulin resistance in liver and peripheral tissue may play a differential role in the pathogenesis of diabetes, this analysis can serve as a simple one-step approach to obtain metabolic indexes specific to EGP suppression and stimulating glucose uptake.

[1]  L. Groop,et al.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.

[2]  M. Stumvoll,et al.  Renal glucose production and utilization: new aspects in humans , 1997, Diabetologia.

[3]  A. Cherrington,et al.  Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. , 1999, Diabetes.

[4]  R. N. Bergman,et al.  Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein? , 2000, Diabetologia.

[5]  Hiroaki Tanaka,et al.  S(G), S(I), and EGP of exercise-trained middle-aged men estimated by a two-compartment labeled minimal model. , 2002, American journal of physiology. Endocrinology and metabolism.

[6]  R. Rizza,et al.  Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes. , 2004, Diabetes.

[7]  Y. Tamura,et al.  Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients. , 2005, The Journal of clinical endocrinology and metabolism.

[8]  Paolo Vicini,et al.  Integrated model of hepatic and peripheral glucose regulation for estimation of endogenous glucose production during the hot IVGTT. , 2005, American journal of physiology. Endocrinology and metabolism.

[9]  M. Hawkins,et al.  The regulation of glucose effectiveness: how glucose modulates its own production , 2005, Current opinion in clinical nutrition and metabolic care.